News
SDS5000X HD and SDS5000L oscilloscopes offer up 8-channels, a bandwidth up to 1 GHz and mark a significant advancement in ...
Evobrutinib was the first BTK inhibitor to show proof-of-concept in a phase 2 trial, but failed two phase 3 trials in relapsing MS last year and was shelved.
Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The ...
Researchers developed a copper-based growth process that produces large-area trilayer graphene films with uniform thickness ...
A novel control scheme for three-phase PWM rectifier is proposed in the paper which improves variable-frequency hysteresis-current control and space vector control due to the fact that there are ...
A model predictive control (MPC) method coupled with a novel asymmetrical modulation of a unique set of virtual voltage vectors to suppress the high-frequency common-mode (CM) voltage in dual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results